Surgical options after Fontan failure

Joost P. Melle, van, Djoeke Wolff, Juergen Hoerer, Emre Belli, Bart Meyns, Massimo Padalino, Harald Lindberg, Jeffrey P. Jacobs, Ilkka P. Mattila, Hakan Berggren, Rolf M. F. Berger, Rene Pretre, Mark G. Hazekamp, Morten Helvind, Matej Nosal, Tomas Tlaskal, Jean Rubay, Stojan Lazarov, Alexander Kadner, Viktor HraskaJose Fragata, Marco Pozzi, George Sarris, Guido Michielon, Duccio di Carlo, Tjark Ebels

OnderzoeksoutputAcademicpeer review

33 Citaten (Scopus)

Samenvatting

OBJECTIVE: The objective of this European multicenter study was to report surgical outcomes of Fontan takedown, Fontan conversion and heart transplantation (HTX) for failing Fontan patients in terms of all-cause mortality and (re-)HTX.

METHODS: A retrospective international study was conducted by the European Congenital Heart Surgeons Association among 22 member centres. Outcome of surgery to address failing Fontan was collected in 225 patients among which were patients with Fontan takedown (n=38; 17%), Fontan conversion (n=137; 61%) or HTX (n=50; 22%).

RESULTS: The most prevalent indication for failing Fontan surgery was arrhythmia (43.6%), but indications differed across the surgical groups (p<0.001). Fontan takedown was mostly performed in the early postoperative phase after Fontan completion, while Fontan conversion and HTX were mainly treatment options for late failure. Early (30 days) mortality was high for Fontan takedown (ie, 26%). Median follow-up was 5.9 years (range 0-23.7 years). The combined end point mortality/HTX was reached in 44.7% of the Fontan takedown patients, in 26.3% of the Fontan conversion patients and in 34.0% of the HTX patients, respectively (log rank p=0.08). Survival analysis showed no difference between Fontan conversion and HTX (p=0.13), but their ventricular function differed significantly. In patients who underwent Fontan conversion or HTX ventricular systolic dysfunction appeared to be the strongest predictor of mortality or (re-)HTX. Patients with valveless atriopulmonary connection (APC) take more advantage of Fontan conversion than patients with a valve-containing APC (p=0.04).

CONCLUSIONS: Takedown surgery for failing Fontan is mostly performed in the early postoperative phase, with a high risk of mortality. There is no difference in survival after Fontan conversion or HTX.

Originele taal-2English
Pagina's (van-tot)1127-1133
Aantal pagina's7
TijdschriftHeart
Volume102
Nummer van het tijdschrift14
DOI's
StatusPublished - jul-2016

Citeer dit